Gilead’s anti-COVID Veklury reduces risk of death
Starting Veklury (remdesivir) within the first two days of hospitalization for COVID-19 can reduce mortality and decrease readmission rates for all hospitalized patients, regardless […]
Gilead’s anti-COVID Veklury reduces risk of death Read More »